COPA: A clinical program to evaluate benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder.
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44DA061908-01A1
Description
SBIR Phase Phase I award: "COPA: A clinical program to evaluate benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder." awarded to BERKSHIRE BIOMEDICAL CORPORATION in Dallas, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $326,410. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.gov